ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Cancer Mortality Rate Down 1.3 Percent, ACS Report Finds

July 30, 2010

AACR Changes Its Logo— For The Fifth Time Since 2000

July 11, 2014

Blood Test Could Predict Relapse, Survival For Children, Young Adults With Leukemia

May 25, 2007

Varmus Pledges No Funding Gap for NCORP, Blames Snafu On “Unclear Communication”

April 11, 2014

Obituary: Ronald Herberman, 72, UPCI Founding Director

July 3, 2013

NCI Advisors Approve Expansion Of CCOPs, Minority-Based CCOPs; Approve Reissuance Of BMT Network RFA, RFPs For Preclinical Drug Studies

November 13, 2009